Literature DB >> 20443916

Increased phosphorylation-dependent nuclear export of class II histone deacetylases in failing human heart.

Mihail B Calalb1, Timothy A McKinsey, Scott Newkirk, Khai Huynh, Carmen C Sucharov, Michael R Bristow.   

Abstract

In the failing human heart (FHH) the induction of a fetal contractile protein gene program is directly and selectively associated with the dilated cardiomyopathy (DCM) phenotype and involves multiple signaling pathways. In response to cardiac stress signals, class II HDACs are subject to phosphorylation dependent nuclear export, which allows for activation of fetal cardiac genes via the transcription factor MEF2. The current study tests the hypothesis that MEF2 activation produced by class II HDAC de-repression is present in the FHH. In this study, human left ventricular tissue from nonfailing and failing adult hearts was analyzed for the presence of MEF2, HDACs 4 and 5. CaMK and HDAC kinase activities were measured in tissue homogenates. In nuclear fractions from failing ventricles, HDAC4 and HDAC5 protein was decreased versus nonfailing controls. MEF2 was not reduced in failing nuclear fractions. CaMK and HDAC kinase activities were increased in failing versus nonfailing hearts. PKCmu (PKD1) activity was increased in nuclear fractions from failing human LVs. These data provide support for decreased nuclear compartment class II HDACs in the FHH, associated with increased activities of kinases known to phosphorylate class II HDACs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20443916      PMCID: PMC5350751          DOI: 10.1111/j.1752-8062.2009.00141.x

Source DB:  PubMed          Journal:  Clin Transl Sci        ISSN: 1752-8054            Impact factor:   4.689


  30 in total

Review 1.  Functional significance of histone deacetylase diversity.

Authors:  S Khochbin; A Verdel; C Lemercier; D Seigneurin-Berny
Journal:  Curr Opin Genet Dev       Date:  2001-04       Impact factor: 5.578

Review 2.  Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins.

Authors:  B L Black; E N Olson
Journal:  Annu Rev Cell Dev Biol       Date:  1998       Impact factor: 13.827

3.  Activity of cAMP-dependent protein kinase and Ca2+/calmodulin-dependent protein kinase in failing and nonfailing human hearts.

Authors:  U Kirchhefer; W Schmitz; H Scholz; J Neumann
Journal:  Cardiovasc Res       Date:  1999-04       Impact factor: 10.787

Review 4.  Histone deacetylases (HDACs): characterization of the classical HDAC family.

Authors:  Annemieke J M de Ruijter; Albert H van Gennip; Huib N Caron; Stephan Kemp; André B P van Kuilenburg
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

5.  Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium.

Authors:  B D Lowes; W Minobe; W T Abraham; M N Rizeq; T J Bohlmeyer; R A Quaife; R L Roden; D L Dutcher; A D Robertson; N F Voelkel; D B Badesch; B M Groves; E M Gilbert; M R Bristow
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

6.  Myosin heavy chain gene expression in human heart failure.

Authors:  K Nakao; W Minobe; R Roden; M R Bristow; L A Leinwand
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

7.  Activation of the myocyte enhancer factor-2 transcription factor by calcium/calmodulin-dependent protein kinase-stimulated binding of 14-3-3 to histone deacetylase 5.

Authors:  T A McKinsey; C L Zhang; E N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

8.  CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo.

Authors:  R Passier; H Zeng; N Frey; F J Naya; R L Nicol; T A McKinsey; P Overbeek; J A Richardson; S R Grant; E N Olson
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

9.  Ca2+/calmodulin-dependent protein kinase IIdelta and protein kinase D overexpression reinforce the histone deacetylase 5 redistribution in heart failure.

Authors:  Julie Bossuyt; Kathryn Helmstadter; Xu Wu; Hugh Clements-Jewery; Robert S Haworth; Metin Avkiran; Jody L Martin; Steven M Pogwizd; Donald M Bers
Journal:  Circ Res       Date:  2008-01-24       Impact factor: 17.367

10.  Regulation of the MEF2 family of transcription factors by p38.

Authors:  M Zhao; L New; V V Kravchenko; Y Kato; H Gram; F di Padova; E N Olson; R J Ulevitch; J Han
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

View more
  14 in total

1.  Epigallocatechin-3-gallate regulates the expression of Kruppel-like factor 4 through myocyte enhancer factor 2A.

Authors:  Yuwen Ma; Youkui Shi; Wenmei Li; Aijuan Sun; Ping Zang; Peirong Zhang
Journal:  Cell Stress Chaperones       Date:  2013-07-25       Impact factor: 3.667

2.  Approaches for Studying the Subcellular Localization, Interactions, and Regulation of Histone Deacetylase 5 (HDAC5).

Authors:  Amanda J Guise; Ileana M Cristea
Journal:  Methods Mol Biol       Date:  2016

3.  14q12 and severe Rett-like phenotypes: new clinical insights and physical mapping of FOXG1-regulatory elements.

Authors:  Lila Allou; Laetitia Lambert; Daniel Amsallem; Eric Bieth; Patrick Edery; Anne Destrée; François Rivier; David Amor; Elizabeth Thompson; Julian Nicholl; Michael Harbord; Christophe Nemos; Aline Saunier; Aissa Moustaïne; Adeline Vigouroux; Philippe Jonveaux; Christophe Philippe
Journal:  Eur J Hum Genet       Date:  2012-06-27       Impact factor: 4.246

4.  β-Adrenergic receptor stimulation and activation of protein kinase A protect against α1-adrenergic-mediated phosphorylation of protein kinase D and histone deacetylase 5.

Authors:  Carmen C Sucharov; Karen Dockstader; Karin Nunley; Timothy A McKinsey; Michael Bristow
Journal:  J Card Fail       Date:  2011-04-22       Impact factor: 5.712

5.  Acute β-adrenergic activation triggers nuclear import of histone deacetylase 5 and delays G(q)-induced transcriptional activation.

Authors:  Chia-Wei Jenny Chang; Linda Lee; David Yu; Khanha Dao; Julie Bossuyt; Donald M Bers
Journal:  J Biol Chem       Date:  2012-11-16       Impact factor: 5.157

6.  Beta-adrenergic adaptation in paediatric idiopathic dilated cardiomyopathy.

Authors:  Shelley D Miyamoto; Brian L Stauffer; Stephanie Nakano; Rebecca Sobus; Karin Nunley; Penny Nelson; Carmen C Sucharov
Journal:  Eur Heart J       Date:  2012-07-26       Impact factor: 29.983

7.  Thioredoxin 1 is essential for sodium sulfide-mediated cardioprotection in the setting of heart failure.

Authors:  Chad K Nicholson; Jonathan P Lambert; Jeffery D Molkentin; Junichi Sadoshima; John W Calvert
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-01-24       Impact factor: 8.311

8.  Clinical significance of histone deacetylase (HDAC)-1, HDAC-2, HDAC-4, and HDAC-6 expression in human malignant and benign thyroid lesions.

Authors:  Constantinos Giaginis; Paraskevi Alexandrou; Ioanna Delladetsima; Ioanna Giannopoulou; Efstratios Patsouris; Stamatios Theocharis
Journal:  Tumour Biol       Date:  2013-07-20

9.  Aurora B-dependent regulation of class IIa histone deacetylases by mitotic nuclear localization signal phosphorylation.

Authors:  Amanda J Guise; Todd M Greco; Irene Y Zhang; Fang Yu; Ileana M Cristea
Journal:  Mol Cell Proteomics       Date:  2012-08-02       Impact factor: 5.911

Review 10.  cMyBP-C as a promiscuous substrate: phosphorylation by non-PKA kinases and its potential significance.

Authors:  Sonya C Bardswell; Friederike Cuello; Jonathan C Kentish; Metin Avkiran
Journal:  J Muscle Res Cell Motil       Date:  2011-11-17       Impact factor: 2.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.